<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D317E8C1-3E16-4E48-8AAC-E2A0961F5299"><gtr:id>D317E8C1-3E16-4E48-8AAC-E2A0961F5299</gtr:id><gtr:name>Erasmus University Medical Center</gtr:name><gtr:address><gtr:line1>PO Box 2040</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2FC62E1F-0AE0-4419-877A-F4A734117E6D"><gtr:id>2FC62E1F-0AE0-4419-877A-F4A734117E6D</gtr:id><gtr:name>University of Florence</gtr:name><gtr:address><gtr:line1>via Luigi Sacconi, 6</gtr:line1><gtr:line3>Sesto Fiorentino</gtr:line3><gtr:postCode>1-50019</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A8D5EA8E-72F4-4F06-B9DE-6AD73CF5651C"><gtr:id>A8D5EA8E-72F4-4F06-B9DE-6AD73CF5651C</gtr:id><gtr:name>University of Western Ontario</gtr:name><gtr:address><gtr:line1>1393 Western Road, SSB 5150</gtr:line1><gtr:postCode>N6G 1G9</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Institute of Neurology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D317E8C1-3E16-4E48-8AAC-E2A0961F5299"><gtr:id>D317E8C1-3E16-4E48-8AAC-E2A0961F5299</gtr:id><gtr:name>Erasmus University Medical Center</gtr:name><gtr:address><gtr:line1>PO Box 2040</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2FC62E1F-0AE0-4419-877A-F4A734117E6D"><gtr:id>2FC62E1F-0AE0-4419-877A-F4A734117E6D</gtr:id><gtr:name>University of Florence</gtr:name><gtr:address><gtr:line1>via Luigi Sacconi, 6</gtr:line1><gtr:line3>Sesto Fiorentino</gtr:line3><gtr:postCode>1-50019</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD"><gtr:id>C7FBE408-C743-4AAC-9BC6-65E14BC8D2FD</gtr:id><gtr:name>Karolinska Institute</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:line4>Stockholm</gtr:line4><gtr:postCode>SE-171 77</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A8D5EA8E-72F4-4F06-B9DE-6AD73CF5651C"><gtr:id>A8D5EA8E-72F4-4F06-B9DE-6AD73CF5651C</gtr:id><gtr:name>University of Western Ontario</gtr:name><gtr:address><gtr:line1>1393 Western Road, SSB 5150</gtr:line1><gtr:postCode>N6G 1G9</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Canada</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B475F34D-A340-48D6-AEE4-BB6C9E7CD25A"><gtr:id>B475F34D-A340-48D6-AEE4-BB6C9E7CD25A</gtr:id><gtr:firstName>Sebastien</gtr:firstName><gtr:surname>Ourselin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/654E5DB9-06ED-4316-B9B9-4DAC598FE9A7"><gtr:id>654E5DB9-06ED-4316-B9B9-4DAC598FE9A7</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Nestor</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/948FC002-4AC3-4BDA-9EB0-969E253ACB3E"><gtr:id>948FC002-4AC3-4BDA-9EB0-969E253ACB3E</gtr:id><gtr:firstName>Jason</gtr:firstName><gtr:surname>Warren</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/72CFEFDB-B0A7-4E8E-8086-F3EFA22B8CFE"><gtr:id>72CFEFDB-B0A7-4E8E-8086-F3EFA22B8CFE</gtr:id><gtr:firstName>Jonathan Daniel</gtr:firstName><gtr:surname>Rohrer</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/5B264FD6-EE14-4E6D-B52A-BC7460F89146"><gtr:id>5B264FD6-EE14-4E6D-B52A-BC7460F89146</gtr:id><gtr:firstName>Martin</gtr:firstName><gtr:otherNames>Neil</gtr:otherNames><gtr:surname>Rossor</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0932C3A1-F583-423C-B002-21350ECA4F57"><gtr:id>0932C3A1-F583-423C-B002-21350ECA4F57</gtr:id><gtr:firstName>James</gtr:firstName><gtr:surname>Rowe</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/73771842-1F5F-417D-B3E9-1C95161A8FA9"><gtr:id>73771842-1F5F-417D-B3E9-1C95161A8FA9</gtr:id><gtr:firstName>Nick</gtr:firstName><gtr:otherNames>Charles</gtr:otherNames><gtr:surname>Fox</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MR%2FJ009482%2F1"><gtr:id>EA859797-C459-4E2D-8CE0-58CABCC8D70B</gtr:id><gtr:title>The GENetic Frontotemporal Dementia Initiative (GENFI): a new multi-centre platform for the study of frontotemporal lobar degeneration</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/J009482/1</gtr:grantReference><gtr:abstractText>The frontotemporal lobar degenerations (FTLD) are a group of dementias characterized by progressive loss of brain cells from the frontal and temporal lobes. Frequently affecting a relatively younger age group compared with other dementias they collectively constitute a major socio-economic and human burden. FTLD commonly runs in families with many patients having a particular genetic mutation as the cause of their disease. The heritable nature of FTLD amplifies the human cost of these diseases but also creates a unique opportunity for making an earlier diagnosis and intervening at an early stage of disease. The understanding of FTLD has hugely advanced in recent years but this has yet to lead to any effective disease-modifying therapies. It is likely that any further progress towards this goal will depend on collaboration between specialist centres. The GENetic Frontotemporal Dementia Initiative (GENFI) aims to unite the expertise and resources of five internationally recognised research departments in the field. The objective of GENFI will be to set up a multi-national consortium with a common platform for the assessment of genetic FTLD patients. Clinical, behavioural, brain imaging, spinal fluid and blood sample data will be collected with the aim of developing markers of the onset and progression of disease in FTLD. Ultimately, the study will explore the feasibility of using the common framework developed here to support future large-scale studies of FTLD, in particular the development of clinical trials of disease-modifying interventions.</gtr:abstractText><gtr:technicalSummary>The frontotemporal lobar degenerations (FTLD) are a group of dementias characterized by progressive loss of brain cells from the frontal and temporal lobes. Frequently affecting a relatively younger age group compared with other dementias they collectively constitute a major socio-economic and human burden. FTLD commonly runs in families with many patients having a particular genetic mutation as the cause of their disease. The heritable nature of FTLD amplifies the human cost of these diseases but also creates a unique opportunity for making an earlier diagnosis and intervening at an early stage of disease. The understanding of FTLD has hugely advanced in recent years but this has yet to lead to any effective disease-modifying therapies. It is likely that any further progress towards this goal will depend on collaboration between specialist centres. The GENetic Frontotemporal Dementia Initiative (GENFI) aims to unite the expertise and resources of five internationally recognised research departments in the field. The objective of GENFI will be to set up a multi-national consortium with a common platform for the assessment of genetic FTLD patients. Clinical, behavioural, brain imaging, spinal fluid and blood sample data will be collected with the aim of developing markers of the onset and progression of disease in FTLD. Ultimately, the study will explore the feasibility of using the common framework developed here to support future large-scale studies of FTLD, in particular the development of clinical trials of disease-modifying interventions.</gtr:technicalSummary><gtr:potentialImpactText>It is expected that the research will lead to academic presentations at high-profile international meetings and publications in a range of peer-reviewed journals particularly targeted at clinicians, imaging scientists and neuropsychologists. In addition, the applicants have been closely involved in national and international initiatives that are formulating clinical and research policy in degenerative dementias (Rossor: director of Dementias and Neurodegenerative Diseases Research Network (DeNDRoN); Rohrer: Consensus guidelines for diagnosis of PPA; Rossor, Rohrer, Warren: Consensus guidelines for diagnosis of bvFTD; Rossor, Warren: EFNS Consensus guidelines for diagnosis and management of non-Alzheimer dementias). Ongoing participation in such initiatives will be directly informed by results arising from this research.</gtr:potentialImpactText><gtr:fund><gtr:end>2014-04-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>211668</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska Institute</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Genetic FTD Initiative</gtr:description><gtr:id>3FB83A03-E25A-45A4-85E8-091339050DF9</gtr:id><gtr:impact>This is a proof of concept study and we are preparing a second application with our international collaborators. 

PET TAU scanning has commenced for familial FTD For Work Package 4.</gtr:impact><gtr:partnerContribution>They have worked with us to develop the consortium and increase the size of the patient cohort studied.</gtr:partnerContribution><gtr:piContribution>This grant initially involved five centres and we have engaged with further international centres with an expertise in genetic frontotemporal dementia in order to expand and strengthen the consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Erasmus University Rotterdam (Erasmus Universitair Medisch Centrum EUR)</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>University Medical Center</gtr:department><gtr:description>Genetic FTD Initiative</gtr:description><gtr:id>13BFB287-EF1E-4180-869B-D55C98A6F1FC</gtr:id><gtr:impact>This is a proof of concept study and we are preparing a second application with our international collaborators. 

PET TAU scanning has commenced for familial FTD For Work Package 4.</gtr:impact><gtr:partnerContribution>They have worked with us to develop the consortium and increase the size of the patient cohort studied.</gtr:partnerContribution><gtr:piContribution>This grant initially involved five centres and we have engaged with further international centres with an expertise in genetic frontotemporal dementia in order to expand and strengthen the consortium.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Western Ontario</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>Genetic FTD Initiative</gtr:description><gtr:id>871BECFC-E912-46BD-ACBA-55D8A6C60909</gtr:id><gtr:impact>This is a proof of concept study and we are preparing a second application with our international collaborators. 

PET TAU scanning has commenced for familial FTD For Work Package 4.</gtr:impact><gtr:partnerContribution>They have worked with us to develop the consortium and increase the size of the patient cohort studied.</gtr:partnerContribution><gtr:piContribution>This grant initially involved five centres and we have engaged with further international centres with an expertise in genetic frontotemporal dementia in order to expand and strengthen the consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Brain, Behaviour and Mental Health</gtr:department><gtr:description>Genetic FTD Initiative</gtr:description><gtr:id>4A64A1BD-2073-4DD0-B319-C4F8225F9919</gtr:id><gtr:impact>This is a proof of concept study and we are preparing a second application with our international collaborators. 

PET TAU scanning has commenced for familial FTD For Work Package 4.</gtr:impact><gtr:partnerContribution>They have worked with us to develop the consortium and increase the size of the patient cohort studied.</gtr:partnerContribution><gtr:piContribution>This grant initially involved five centres and we have engaged with further international centres with an expertise in genetic frontotemporal dementia in order to expand and strengthen the consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Florence</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Department of Neurological and Psychiatric Sciences</gtr:department><gtr:description>Genetic FTD Initiative</gtr:description><gtr:id>A2EB46C7-58B1-4F78-BC98-376F640E5D07</gtr:id><gtr:impact>This is a proof of concept study and we are preparing a second application with our international collaborators. 

PET TAU scanning has commenced for familial FTD For Work Package 4.</gtr:impact><gtr:partnerContribution>They have worked with us to develop the consortium and increase the size of the patient cohort studied.</gtr:partnerContribution><gtr:piContribution>This grant initially involved five centres and we have engaged with further international centres with an expertise in genetic frontotemporal dementia in order to expand and strengthen the consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>6-7 April 2016, DZNE (Bonn)&quot;The role of genetic cohorts in bridging clinical and basic science&quot;</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>8D7DD2D7-4946-4744-B2F7-235854E5E6F6</gtr:id><gtr:impact>Discussion of the role of Genetic cohorts to advise the German Neurodegenerative disease research network</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Familial FTD support group</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E0EB382A-EAD1-4AA2-91AE-9CF8D328E644</gtr:id><gtr:impact>Talk to around 100 people as part of the familial FTD support group annual day - discussion about GENFI and current research; questions and discussion about research from family members and those at risk of developing genetic FTD.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:url>https://www.ucl.ac.uk/drc/support-groups/fFTD-support-group</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Scientific Advisory Board meeting of the EU Joint Programme on neurodegenerative disease (January 2014)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>783B8144-F65D-48CD-802F-3D0FAB250218</gtr:id><gtr:impact>Discussion around disease definitions and diagnosis

-</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Sidney de Haan lecture (May 2014)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>1615BD31-39B5-4DDC-914E-B30E4B0B16A7</gtr:id><gtr:impact>Discussion on frontotemporal dementia &amp;amp; what we learn from our patients



-</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>5-7 October 2016, CCNA ISAB (Vancouver)(premanifest disease &amp; cognitive footprint?)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E5F523D3-6B9E-4449-A91F-EE9E3E05B1C8</gtr:id><gtr:impact>Plenary lecture at Canadian consortium on Neurodegeneration and aging</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EADC</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>223FEAC5-C4B4-451D-87B9-FCFDDC39AC80</gtr:id><gtr:impact>Invited to speak at the European Alzheimer's Disease Collaboration meeting in Monte Carlo in October 2012, to 40 other primary investigators from across Europe.

2 sites interested in joining collaboration after presentation.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Familial FTD Meeting 16 Jul 14</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>27B35CA8-4648-49DC-A710-6630FEE39701</gtr:id><gtr:impact>Patient and carer input into planning future activities

-</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>FTD/GENFI Support Group 23Nov13</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>FFD7910C-E707-4CB5-9F0D-808FC3C08094</gtr:id><gtr:impact>Patient and carer input into planning future activities.

-</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>FTD Cohort Presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A8A938C9-E204-448C-8D2D-C04790295E5D</gtr:id><gtr:impact>The FTD cohort was discussed at the annual ARUK Centre Public Engagement Activities.

We have also established a familial dementia patient group.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>GENFI Investigators' Meeting and Dinner 4 July 2013</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A2D9A95E-2B7A-43F5-AE59-79C80B403730</gtr:id><gtr:impact>Plans for analysis of data and future grant applications

National Grant Applications by our international colleagues.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British  NeuroPsychiatric Association Annual meeting 24th February - medalist Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A0A9E4AF-3C70-4755-AC3D-68E097F28803</gtr:id><gtr:impact>Discussion of nosological challanges in Dementia</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://bnpa.org.uk/wp-content/uploads/2017/02/BNPA-FINAL-PROGRAMME-2017.pdf</gtr:url><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited Speaker at FTD Conference in San Francisco 14-16Nov13</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>53743F9E-7B2B-403C-BC19-CDA3B25E5EC5</gtr:id><gtr:impact>This is the major annual FTD conference

-</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description> 26 April 2016, DPUK Annual Conference</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>20CAFDFC-C0F9-44C5-93F5-C31F58FBCBC4</gtr:id><gtr:impact>DPUK Open Day</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.dementiasplatform.uk/wp-content/uploads/2016/06/Conference-Programme.pdf</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>34178</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>JPND - Working Groups to Inform Cohort Studies in Neurodegenerative Disease Research</gtr:description><gtr:end>2015-05-02</gtr:end><gtr:fundingOrg>EU Joint Programme - Neurodegenerative Disease Research (JPND)</gtr:fundingOrg><gtr:id>A9D52B6E-4A0D-4B6C-8603-145FAFA6312D</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6236753</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Dementias Platform</gtr:description><gtr:end>2019-03-02</gtr:end><gtr:fundingOrg>MRC-UK</gtr:fundingOrg><gtr:fundingRef>CSUB19166</gtr:fundingRef><gtr:id>1616EE1A-71FE-485D-8A79-97BD2868A6A6</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Development of a methodological framework of presymptomatic clinical trials</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>E7DE7CF9-88E6-4D1E-B339-837326FBE8FF</gtr:id><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Database of biomarker data from the GENFI 1 and GENFI 2 projects (presymptomatic and early symptomatic genetic FTD).</gtr:description><gtr:id>C02D3115-0110-4E39-9A40-949CEBAEB3DF</gtr:id><gtr:impact>17 current analyses ongoing across multiple centres within GENFI - aiming for publications in 2016.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>GENFI XNAT database</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>The DPUK is creating the world's largest population study for use in dementias research, bringing together two million participants aged 50 and over, from 22 existing study groups within the UK. Included are people from the general population, people known to be at-risk of developing dementia, and people diagnosed with early-stage dementia.</gtr:description><gtr:id>9486D724-CA82-4873-B489-2A27C1F909D6</gtr:id><gtr:impact>By adding to information that we already know about the participants (such as their diet, exercise habits and previous infections) we hope to identify cognitive, genetic, physiological and imaging measures (biomarkers) to understand who is at risk of developing dementia and why the progression of dementia varies from person to person.
 
The DPUK is taking a new approach that considers what is happening to the health of the person - looking not just at the brain but at the brain in the context of the whole body - to identify those changes that may best be associated with the early stages of dementia. Emerging evidence has linked the development of dementia with inflammatory, cardiovascular and metabolic events and disorders, and the DPUK will be able to test these interactions, potentially identifying new treatment options to both manage symptoms, in the near term, and for preventive approaches in the longer term.
 
The platform will further allow the testing and validation of novel hypotheses by studying and comparing data from different DPUK cohorts. This will provide valuable feedback to inform future mechanistic research for example using stem cells or animal models.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>MRC Dementia Platform UK</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.mrc.ac.uk/research/facilities/dementias-platform-uk/</gtr:url><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Repository of CSF and serum samples from subjects in the GENFI study.</gtr:description><gtr:id>67B85B4C-AABE-47FB-8124-6C938F9A5609</gtr:id><gtr:impact>to be provided by Jonathan Rohrer</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>GENFI Biobank</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/93996C53-F9D8-4ADF-8DFA-8619324A88E8"><gtr:id>93996C53-F9D8-4ADF-8DFA-8619324A88E8</gtr:id><gtr:title>Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b9daf1044ffaa78c220fa83b15b9c753"><gtr:id>b9daf1044ffaa78c220fa83b15b9c753</gtr:id><gtr:otherNames>Ferrari R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1F04AD28-AE4D-4F42-947A-1DA6EE847575"><gtr:id>1F04AD28-AE4D-4F42-947A-1DA6EE847575</gtr:id><gtr:title>The frontotemporal lobar degenerations as 'molecular nexopathies'</gtr:title><gtr:parentPublicationTitle>DEMENTIA AND GERIATRIC COGNITIVE DISORDERS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3d7b17eeb7060f01b0a999c9009a82a0"><gtr:id>3d7b17eeb7060f01b0a999c9009a82a0</gtr:id><gtr:otherNames>Warren Jason</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1420-8008</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F00B6935-8DB7-4C43-8807-DA76A62E28F1"><gtr:id>F00B6935-8DB7-4C43-8807-DA76A62E28F1</gtr:id><gtr:title>The clinical spectrum of sporadic and familial forms of frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a00619128624465a296dd67279e6d575"><gtr:id>a00619128624465a296dd67279e6d575</gtr:id><gtr:otherNames>Woollacott IO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/457F93DE-C6C0-48F9-93BB-928A5C403E02"><gtr:id>457F93DE-C6C0-48F9-93BB-928A5C403E02</gtr:id><gtr:title>Neurofilament light chain: a biomarker for genetic frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Annals of clinical and translational neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7d9a6eebd99b20afa7e12330bb7739e5"><gtr:id>7d9a6eebd99b20afa7e12330bb7739e5</gtr:id><gtr:otherNames>Meeter LH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2328-9503</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/64A919A5-BBEC-4E2E-9A6D-83D33015B370"><gtr:id>64A919A5-BBEC-4E2E-9A6D-83D33015B370</gtr:id><gtr:title>GENFI - The GENetic Frontotemporal dementia Initiative</gtr:title><gtr:parentPublicationTitle>DEMENTIA AND GERIATRIC COGNITIVE DISORDERS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4ff0bbf738743a9bb5c95a2d4c385ab5"><gtr:id>4ff0bbf738743a9bb5c95a2d4c385ab5</gtr:id><gtr:otherNames>Rohrer Jonathan</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1420-8008</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A3D2128A-D40C-4A7B-BA50-BFC4365B942E"><gtr:id>A3D2128A-D40C-4A7B-BA50-BFC4365B942E</gtr:id><gtr:title>Presymptomatic studies in genetic frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Revue neurologique</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0035-3787</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8D646BA5-FC06-4264-AAE7-D8E7BDEE7A1C"><gtr:id>8D646BA5-FC06-4264-AAE7-D8E7BDEE7A1C</gtr:id><gtr:title>THE EVOLUTION OF FRONTOTEMPORAL DEMENTIA DUE TO THE MAPT MUTATION: A SEVENTEEN YEAR NATURAL HISTORY STUDY</gtr:title><gtr:parentPublicationTitle>Journal of Neurology, Neurosurgery &amp; Psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3c8ca28a4bb4076a033d81bcc069b790"><gtr:id>3c8ca28a4bb4076a033d81bcc069b790</gtr:id><gtr:otherNames>Mahoney C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/623AFA8C-7F9F-476C-9441-F5DB2DF5EA04"><gtr:id>623AFA8C-7F9F-476C-9441-F5DB2DF5EA04</gtr:id><gtr:title>Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/06052EE5-3C11-49FF-8BB8-ED5CB8C4B397"><gtr:id>06052EE5-3C11-49FF-8BB8-ED5CB8C4B397</gtr:id><gtr:title>Neurofilament light chain: a biomarker for genetic frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Annals of clinical and translational neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7d9a6eebd99b20afa7e12330bb7739e5"><gtr:id>7d9a6eebd99b20afa7e12330bb7739e5</gtr:id><gtr:otherNames>Meeter LH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2328-9503</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/06151D6B-9AAF-4F60-A2B5-680B3EF66295"><gtr:id>06151D6B-9AAF-4F60-A2B5-680B3EF66295</gtr:id><gtr:title>Clinical review. Frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/53d738fa9ba6d1c8484ec4f210b08967"><gtr:id>53d738fa9ba6d1c8484ec4f210b08967</gtr:id><gtr:otherNames>Warren JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/824D6534-19C7-4705-A39D-CDD4156E431B"><gtr:id>824D6534-19C7-4705-A39D-CDD4156E431B</gtr:id><gtr:title>Frontotemporal dementia and its subtypes: a genome-wide association study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b9daf1044ffaa78c220fa83b15b9c753"><gtr:id>b9daf1044ffaa78c220fa83b15b9c753</gtr:id><gtr:otherNames>Ferrari R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/351095BD-CDCF-45A5-92E6-E77B43337F31"><gtr:id>351095BD-CDCF-45A5-92E6-E77B43337F31</gtr:id><gtr:title>Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3C5C048B-760E-412D-87E6-1E562A9A9424"><gtr:id>3C5C048B-760E-412D-87E6-1E562A9A9424</gtr:id><gtr:title>The habenula: an under-recognised area of importance in frontotemporal dementia?</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/91e8dbd4552d3ca97e5829f2f97fc986"><gtr:id>91e8dbd4552d3ca97e5829f2f97fc986</gtr:id><gtr:otherNames>Bocchetta M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4E94D97A-BECB-4EF7-92DB-A1AD29F89A21"><gtr:id>4E94D97A-BECB-4EF7-92DB-A1AD29F89A21</gtr:id><gtr:title>The clinical, neuroanatomical, and neuropathologic phenotype of TBK1-associated frontotemporal dementia: A longitudinal case report.</gtr:title><gtr:parentPublicationTitle>Alzheimer's &amp; dementia (Amsterdam, Netherlands)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/897d235c34e30e62338fa17ff2c4efa6"><gtr:id>897d235c34e30e62338fa17ff2c4efa6</gtr:id><gtr:otherNames>Koriath CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/238B9E1A-32B1-4DC5-9E17-1D182C99FC78"><gtr:id>238B9E1A-32B1-4DC5-9E17-1D182C99FC78</gtr:id><gtr:title>Detailed volumetric analysis of the hypothalamus in behavioral variant frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/91e8dbd4552d3ca97e5829f2f97fc986"><gtr:id>91e8dbd4552d3ca97e5829f2f97fc986</gtr:id><gtr:otherNames>Bocchetta M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F479483B-49A7-42E3-A82E-F4DA5C74C8CE"><gtr:id>F479483B-49A7-42E3-A82E-F4DA5C74C8CE</gtr:id><gtr:title>Binary reversals in primary progressive aphasia.</gtr:title><gtr:parentPublicationTitle>Cortex; a journal devoted to the study of the nervous system and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/53d738fa9ba6d1c8484ec4f210b08967"><gtr:id>53d738fa9ba6d1c8484ec4f210b08967</gtr:id><gtr:otherNames>Warren JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0010-9452</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4D761C5A-3270-44E5-8CB5-F5F5FFC8B901"><gtr:id>4D761C5A-3270-44E5-8CB5-F5F5FFC8B901</gtr:id><gtr:title>C9orf72 mutations and the puzzle of cerebro-cerebellar network degeneration.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6ea1feb377e0b3a562dd1f424ed51ab7"><gtr:id>6ea1feb377e0b3a562dd1f424ed51ab7</gtr:id><gtr:otherNames>Marshall CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5373DE91-03BE-43DB-B650-AFDAB0B45D98"><gtr:id>5373DE91-03BE-43DB-B650-AFDAB0B45D98</gtr:id><gtr:title>Creation of an open-access, mutation-defined fibroblast resource for neurological disease research.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/68ca09ebb1473b9780612d7b5d9dafef"><gtr:id>68ca09ebb1473b9780612d7b5d9dafef</gtr:id><gtr:otherNames>Wray S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/50E6382E-82F0-4E40-8BA5-94C42ACD58B5"><gtr:id>50E6382E-82F0-4E40-8BA5-94C42ACD58B5</gtr:id><gtr:title>C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2737E6D9-B4FF-414B-9256-0C749C9425A8"><gtr:id>2737E6D9-B4FF-414B-9256-0C749C9425A8</gtr:id><gtr:title>Binary reversals in primary progressive aphasia.</gtr:title><gtr:parentPublicationTitle>Cortex; a journal devoted to the study of the nervous system and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/53d738fa9ba6d1c8484ec4f210b08967"><gtr:id>53d738fa9ba6d1c8484ec4f210b08967</gtr:id><gtr:otherNames>Warren JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0010-9452</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/433D4134-A9F8-4CB2-AB88-30B0EEE3C697"><gtr:id>433D4134-A9F8-4CB2-AB88-30B0EEE3C697</gtr:id><gtr:title>Biomarkers in frontotemporal dementia.</gtr:title><gtr:parentPublicationTitle>Biomarkers in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1752-0363</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/J009482/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>